Rüssel, J.; Einem, J. von; Keilholz, U.; Dietz, A.; Grünewald, V; Maschmeyer, G.; Kasper, S.; Rupprecht, M.; Sasse, B.; Melillo, G. and Krauss, J.
(2016):
RAPTOR, the global phase II, III clinical development program of the PD-L1 inhibitor Durvalumab (MEDI4736) in 2nd-line recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) - A German update on the HAWK, EAGLE and CONDOR trials.
In: Oncology Research and Treatment, Vol. 39: pp. 173-174
DOI: 10.1159/000449050
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 2296-5270 |
| Language: | English |
| Item ID: | 46628 |
| Date Deposited: | 27. Apr 2018, 08:11 |
| Last Modified: | 04. Nov 2020, 13:23 |
Actions (login required)
- View Item
